Try our Advanced Search for more refined results
Tanvex BioPharma Inc.
-
Utility | Filed: February 10, 2023 | Entered: March 06, 2023 Genentech, Inc. v. Tanvex BioPharma USA, Inc. et al
Patent | California Southern
Report Regarding Patent & Trademark Closing
REPORT of Patent and Trademark Closing, regarding patent and/or trademark number(s) 10,662,237, 10,808,037, 8,574,869, re 60 Order on Motion to Dismiss. cc:USPTO (rmc)
-
Order | Filed: February 10, 2023 | Entered: February 10, 2023 Genentech, Inc. v. Tanvex BioPharma USA, Inc. et al
Patent | California Southern
Order on Motion to Dismiss
ORDER granting 59 Joint Motion to Dismiss without prejudice. Signed by District Judge Ruth Bermudez Montenegro on 2/10/2023. (jpp)
-
Motion | Filed: February 09, 2023 | Entered: February 09, 2023 Genentech, Inc. v. Tanvex BioPharma USA, Inc. et al
Patent | California Southern
Dismiss
Joint MOTION to Dismiss without Prejudice by Genentech, Inc.. (Nesler, Katherine)
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Archive of over 450,000 articles
- Database of over 2.1 million cases
- 62,000+ organization-specific pages.
- Daily and real-time news and case alerts on organizations, industries, and customized search queries.
- Significant legal events involving law firms, companies, industries, and government agencies.
- Learn more
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login